Lavaca Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.45M | Buy |
65,773
+51,759
| +369% | +$6.06M | 0.83% | 8 |
|
|
2026
Q1 | $1.69M | Buy |
14,014
+3,180
| +29% | +$367K | 0.3% | 32 |
|
|
2025
Q4 | $1.14M | Hold |
10,834
| – | – | 0.18% | 44 |
|
|
2025
Q3 | $909K | Hold |
10,834
| – | – | 0.16% | 47 |
|
|
2025
Q2 | $858K | Hold |
10,834
| – | – | 0.32% | 44 |
|
|
2025
Q1 | $972K | Sell |
10,834
-391
| -3% | -$36.5K | 0.4% | 41 |
|
|
2024
Q4 | $1.12M | Buy |
11,225
+391
| +4% | +$40.3K | 0.44% | 36 |
|
|
2024
Q3 | $1.23M | Buy |
10,834
+100
| +0.9% | +$11.9K | 0.52% | 35 |
|
|
2024
Q2 | $1.33M | Hold |
10,734
| – | – | 0.68% | 22 |
|
|
2024
Q1 | $1.42M | Buy |
10,734
+1,834
| +21% | +$226K | 0.83% | 19 |
|
|
2023
Q4 | $970K | Sell |
8,900
-2,422
| -21% | -$251K | 0.55% | 30 |
|
|
2023
Q3 | $1.17M | Sell |
11,322
-10,592
| -48% | -$1.14M | 0.39% | 52 |
|
|
2023
Q2 | $2.53M | Sell |
21,914
-42,832
| -66% | -$4.86M | 0.74% | 22 |
|
|
2023
Q1 | $6.95M | Buy |
64,746
+727
| +1% | +$78.5K | 1.45% | 10 |
|
|
2022
Q4 | $6.57M | Buy |
64,019
+1,956
| +3% | +$200K | 2.05% | 10 |
|
|
2022
Q3 | $5.52M | Sell |
62,063
-1,029
| -2% | -$91.9K | 1.98% | 11 |
|
|
2022
Q2 | $5.62M | Buy |
63,092
+6,706
| +12% | +$595K | 0.84% | 11 |
|
|
2022
Q1 | $4.63M | Sell |
56,386
-48,696
| -46% | -$3.84M | 0.5% | 23 |
|
|
2021
Q4 | $8.05M | Buy |
105,082
+6
| +0% | +$478 | 1.03% | 8 |
|
|
2021
Q3 | $7.89M | Buy |
105,076
+1,710
| +2% | +$130K | 0.8% | 9 |
|
|
2021
Q2 | $8.04M | Sell |
103,366
-22,219
| -18% | -$1.65M | 0.8% | 10 |
|
|
2021
Q1 | $9.24M | Buy |
125,585
+8,666
| +7% | +$639K | 0.79% | 7 |
|
|
2020
Q4 | $9.13M | Buy |
116,919
+23,173
| +25% | +$1.77M | 1.2% | 7 |
|
|
2020
Q3 | $7.42M | Sell |
93,746
-2,504
| -3% | -$196K | 1.17% | 11 |
|
|
2020
Q2 | $7.1M | Sell |
96,250
-836
| -0.9% | -$62.9K | 2.26% | 6 |
|
|
2020
Q1 | $7.13M | Sell |
97,086
-4,917
| -5% | -$386K | 6.9% | 3 |
|
|
2019
Q4 | $8.85M | Buy |
102,003
+18
| +0% | +$1.48K | 6.8% | 3 |
|
|
2019
Q3 | $8.19M | Sell |
101,985
-412
| -0.4% | -$33K | 6.18% | 3 |
|
|
2019
Q2 | $8.19M | Buy |
102,397
+2,273
| +2% | +$174K | 6.32% | 3 |
|
|
2019
Q1 | $7.95M | Buy |
100,124
+5,240
| +6% | +$392K | 6.77% | 2 |
|
|
2018
Q4 | $6.92M | Buy |
+94,884
| New | +$6.7M | 6.89% | 2 |
|
Other funds holding MRK
Lavaca Capital's MRK Position: Q2 2026 in Review
Lavaca Capital increased its Merck (MRK) stake by 369% in Q2 2026, buying an estimated $6.06M and bringing the position to 65,773 shares worth $8.45M. The position accounts for 0.83% of the portfolio, ranked #8.
Lavaca Capital first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $9.24M in Q1 2021. 3,842 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Lavaca Capital held 65,773 shares of Merck worth $8.45M as of Q2 2026.
- Lavaca Capital bought 51,759 Merck shares in Q2 2026, an estimated $6.06M.
- Merck made up 0.83% of Lavaca Capital's portfolio in Q2 2026, its #8 holding.
- Lavaca Capital first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Lavaca Capital's Merck position peaked at $9.24M in Q1 2021.
- 3,842 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.